Results from Cohorts 4 and 5 of the Phase 2 KEYNOTE-199 Study Published

Jun 30

Written By Kristofer Prepelica, PhD

Kristofer Prepelica, PhD

Prognostic Significance of PSA>0.2 After 6-12 Months Treatment for mHSPC Intensified by ARPIs: A Multinational Real-World Analysis of the IRONMAN Registry